EUCANCan aimed at supporting and enhancing modern oncology, by implementing a cultural, technological and legal integrated framework across Europe and Canada, to enable and facilitate the efficient analysis, management and sharing of cancer genomic data. The project, which ended in June 2023, was coordinated by Prof. David Torrents from the Barcelona Supercomputing Centre (BSC).
This cooperative framework was not only expected to immediately contribute to improve biomedical research in cancer, but to also serve as a model for globalizing and enriching Personalized Medicine initiatives, allowing the exchange of data, clinical experience and information across different national health systems.
View the most important project facts at a glance in the EUCANCan factsheet. Download it here.
EUCANCan built on previous work performed by members of the consortium and related projects to align and interconnect existing European and Canadian infrastructures for the analysis and management of genomic oncology data. The EUCANCan network was composed of reference nodes in Amsterdam, Barcelona, Berlin, Heidelberg, Paris and Toronto which established strong research and clinical programs in the field of genomic oncology.
These reference nodes worked together in a federated and interoperable fashion to provide the genomic oncology community with a uniform computing environment for the processing, harmonization and secure sharing of cancer genome and phenome data in the context of clinical research, enabling the discovery of clinically-relevant patterns of genomic variation in cancer, such as biomarkers predictive of therapeutic response. This infrastructure also provided a proving ground for federated genome analysis systems that may one day be integrated into national and regional healthcare systems.